Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
152.4 USD | +0.64% | +2.27% | -2.81% |
05:35pm | Ten key beauty players | |
09:57am | Kenvue Prices Secondary Common Stock Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.81% | 364B | |
+31.37% | 588B | |
+20.32% | 326B | |
+5.45% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.89% | 167B | |
+0.05% | 161B | |
+0.89% | 124B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Seeks EU Approval for Ulcerative Colitis, Crohn’s Disease Drug